We found that human matrix metalloproteases (MMPs) may be processed from their proenzyme forms (proMMP) to their active forms by two new and unique mechanisms: Firstly, by bacterial proteases such as Pseudomonas elastase and Vibrio cholerae protease, which cleave off the N-terminal autoinhibitory domain (so-called cysteine switch) from proMMPs, The second mechanism depends on free radical generation by activated polymorphonuclear leukocytes (PMNs). In this case, peroxynitrite (ONOO-) or nitrogen dioxide radical ((NO2)-N-.), the reaction products of either superoxide (O-2(.-)) or molecular oxygen (O-2) and nitric oxide ((NO)-N-.), are the key reactants. Both O-2(.-) and (NO)-N-. are generated by activated macrophages and PMNs as a result of immunologic responses involving various proinflammatory cytokines, (NO2)-N-. or ONOO- seems to interact with a single cysteine residue in the propeptide autoinhibitory domain, or so-called cysteine switch of proMMPs, thus transforming proMMPs into their active conformation. Furthermore, reactive oxygen species are known to inactivate the alpha(1)-protease inhibitor (alpha(1)-PI), a potent neutrophil elastase inhibitor in plasma. In addition, we found that such radicals activate MMPs which degrade and inactivate alpha(1)-PI by proteolysis. Thus, the activation of MMPs, accompanied by the inactivation of alpha(1)-PI, will bring about enhanced proteolytic damage to the matrix tissues of the infected sites by both MMPs and elastase.